NDC Pharmacologic Class N0000193616 CD22-directed Antibody Interactions [MoA]

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0008-0100Besponsa Inotuzumab OzogamicinInjection, Powder, Lyophilized, For SolutionIntravenousWyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.Human Prescription Drug

There are 1 NDC products with the pharmacologic class CD22-directed Antibody Interactions [MoA].